SC

Subhash Chandra Vishwakarma

Active Director Director DIN 10502496
DIN 10502496 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Subhash Chandra Vishwakarma

Data last updated:

Subhash Chandra Vishwakarma is a Director at Mephor Biotech Private Limited (since 2024).

DIN 10502496
Primary Designation Director
First Appointment 10 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mephor Biotech Private Limited U46497UP2024PTC197335
Director10 Feb 20242024Active

Board colleagues of Subhash Chandra Vishwakarma

NameDINCompanyDesignation
Prema Devi10502497Mephor Biotech Private LimitedDirector
Ram Naresh10502495Mephor Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mephor Biotech Private Limited
Premium access

Shareholding and investment profile for Subhash Chandra Vishwakarma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chandra Vishwakarma

Subhash Chandra Vishwakarma currently holds 1 directorship: Mephor Biotech Private Limited (Director, since 10 Feb 2024).

Subhash Chandra Vishwakarma was first appointed on 10 Feb 2024 as Director at Mephor Biotech Private Limited.

The current boards of Subhash Chandra Vishwakarma's companies include Prema Devi (Mephor Biotech Private Limited), Ram Naresh (Mephor Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available